dc.contributor.author | Ertugrul, B. | |
dc.contributor.author | Iplik, E.S. | |
dc.contributor.author | Cakmakoglu, B. | |
dc.date.accessioned | 2021-12-21T08:40:32Z | |
dc.date.available | 2021-12-21T08:40:32Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1884409 | |
dc.identifier.uri | https://doi.org/10.1016/j.arcmed.2020.10.022 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1046 | |
dc.description.abstract | Background and aims: Although several treatment regimens for T-cell acute lymphoblastic leukemia (T-ALL), trouble is still ongoing that relapse of disease after therapies in both pediatric and adult patients. Hence, the demand for new alternative therapeu | |
dc.description.sponsorship | The work was supported by Scientific Research Projects Coordination Unit of Istanbul University in Istanbul, Turkey. Project number: 21449. | |
dc.language.iso | English | |
dc.publisher | Elsevier Inc. | |
dc.title | In Vitro Inhibitory Effect of Succinic Acid on T-Cell Acute Lymphoblastic Leukemia Cell Lines | |
dc.type | Article | |
dc.relation.journal | Archives of Medical Research | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 270 | |
dc.identifier.endpage | 276 | |
dc.identifier.volume | 52 | |
dc.identifier.doi | 10.1016/j.arcmed.2020.10.022 | |
dc.relation.issue | 3 | |
dc.relation.volume | 52 | |